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Abstract
Background: Four vaccine-related polioviruses (VRPV) were isolated from aseptic encephalitis cases in Yunnan,
China in 2010. The genomic sequences of these VRPVs were investigated to gain a better understanding of their
molecular characteristics.
Methods: Molecular typing was performed by amplification and sequencing of the VP1 region. The genomic
sequences of the four VRPV3 strains were compared to vaccine strain and wild strain sequences to study genetic
drift and recombination.
Results: All four isolates could be entirely neutralized by polyclonal poliovirus 3 (PV3) antisera but not by PV1 and
PV2 antisera and displayed a temperature-sensitive phenotype. The genomic sequences of all four isolates
contained two Sabin 3-specific attenuating mutations at nucleotides 472(C→ T) and 2034(C→ T), but a third Sabin 3-
specific attenuating mutation at position 2493 (T→ C) had reverted back to a T. Recombination analyses showed RF108/
YN/CHN/2010 and RF134/YN/CHN/2010 strain recombined with Sabin 2 at the 3′-end of the 2C to 3′-untranslated region
(3′-UTR) and at the 5′-end of the 3D to 3′-UTR, respectively.
Conclusion: Four VRPV3 strains including two type 3/type 2 intertypic recombinants were identified. The recombination
of Sabin vaccine strains with other Sabin serotypes or human enterovirus C species could be a critical factor in the
potential of emerging viruses and related disease outbreaks. Therefore, it is essential to be persistent in the surveillance of
EVs (including PV).
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Background
Polioviruses (PVs) are members of the human entero-
virus C species (HEV-C) of the Enterovirus genus in the
Picornaviridae family, which are small, non-enveloped,
positive single-stranded RNA viruses. The genome of PV
is approximately 7500 nucleotides (nt) in length and
contains an open reading frame (ORF) flanked by a 5′-
untranslated region (UTR) and a 3′-UTR. The ORF is
translated into a polyprotein and is then cleaved into
four capsid proteins (VP1 to VP4) and seven nonstruc-
tural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D). The oral
poliovirus vaccine (OPV) consists of three live attenu-
ated strains that correspond to the three serotypes of
poliovirus (Sabin 1, 2, and 3, for Polio 1, 2, and 3, re-
spectively) [1]. PVs were the main causes of paralytic
disease (poliomyelitis) before PV vaccines were available.
However, poliomyelitis has not been absolutely eradicated,
because the poliomyelitis eradication program is based on
a large-scale vaccination campaign with OPV and the
vaccine-derived polioviruses (VDPVs) or vaccine-related
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polioviruses (VRPVs) have caused sporadic or epidemics
of poliomyelitis in many countries [2–6].
During the replication of Sabin strains in gut cells, rever-
tants with increased virulence and recombination (gene re-
arrangements) can arise, leading to the emergence of
pathogenic VDPVs or VRPVs, which have been found in
patients with acute flaccid paralysis (AFP) [2, 4, 7]. Most
recombinants were found among Sabin 2 and Sabin 3
[8–12], and a small proportion of recombinants were
found among Sabin 1 with Sabin 2 or wild vaccine
[13]. Crossover sites have been found in genomic regions
coding for non-structural and structural proteins [8–13].
Here, we report four VRPV3 strains, including two type
3/type 2 intertypic recombinants, isolated from aseptic en-
cephalitis cases in 2010, China. This finding prompted us to
further explore the complete genome characterization and
temperature-sensitive phenotype of the four VRPV3 isolates.
Results
Primary characterization of the virus isolates
The entire VP1 coding sequences of RF108/YN/CHN/
2010 (RF108), RF134/YN/CHN/2010 (RF134), RF146/YN/
CHN/2010 (RF146) and RF151/YN/CHN/2010 (RF151)
were found to have high homology with PV3/Sabin
(99.8 %). PV3 isolates that are <1.0 % divergent in the VP1
sequence from PV3/Sabin are classified as VRPV [14], the
four isolates belong to VRPV3. Neutralization assay tests
on all four isolates with anti-PV1, 2 and 3 antisera, re-
spectively, revealed that all four isolates were completely
neutralized with polyclonal anti-PV3 antisera but not by
anti-PV1 or anti-PV2 antisera, this further determined a
PV3/Sabin serotype.
Analysis of complete genome sequences
Excluding a small fragment (29 nucleotides) at the 5′-end
of the genomes, the complete genome sequences of the
four VRPV3 isolates were determined. The genomes were
7402 nucleotides in length and consisted of a 5′-UTR of
713 nucleotides followed by a long ORF that encoded a
polyprotein of 2206 amino acids and a 3′-UTR of 71
nucleotides. The variation between these four strains at
the nucleotide and amino acid level were 0.2–4.9 % and
0.2–1.2 %, respectively.
The 3A to 3′-UTR regions of RF108 and 3′-UTR re-
gions of RF134, RF146 and RF151 had most homology
with the corresponding regions of Sabin 2, while other
regions of their genomes had high similarity to the cor-
responding regions of Sabin 3 (Table 1). Importantly, the
two major determinants for the attenuated phenotype of
Sabin 3 were not lost in the four isolates: T472 in the
5′-UTR and U2034 (also identified as Phe91) in the VP3
region [15]. Another Sabin 3-specific mutation at pos-
ition 2493 (T→C), which predicts an Ile→ Thr (at resi-
due 6 of VP1) change that was found to have
attenuating neurovirulence in monkeys [16], had
reverted back to a T in all four isolates. Except for in the
Sabin 3 and PV3 NIE1018453 strain, the position T2493
of other PV3 isolates was identical to the wild poliovirus
type 3 (WPV3) strain P3/Leon/37(type 3) (Table 2).
The amino acid sequences within or near the pre-
dicted neutralizing antigenic (NAg) sites were identified
in an alignment of the four isolates, Sabin 3, Sabin 2 and
16 VRPV3 strains and P3/Leon/37(type 3). Except for
the RF151 strain, there were no amino acid substitutions
at NAg sites in the other three isolates (Additional file 1:
Figure S1). Sabin-specific antigenic epitopes were




RF108 RF134 RF146 RF151
Sabin 1 Sabin 2 Sabin 3 Sabin 1 Sabin 2 Sabin 3 Sabin 1 Sabin 2 Sabin 3 Sabin 1 Sabin 2 Sabin 3
5′UTR 80.3 80.4 99.9 80.3 80.4 99.9 80.3 80.4 99.9 80.0 80.2 99.6
VP4 77.3 (92.8) 75.2 (90.6) 100 (100) 77.3 (92.8) 75.2 (92.6) 100 (100) 77.3 (92.8) 75.2 (92.6) 100 (100) 77.3 (92.8) 75.2 (92.6) 100 (100)
VP2 70.3 (82.4) 70.2 (81.2) 99.9 (100) 70.3 (82.4) 70.2 (81.2) 99.9 (100) 70.3 (82.4) 70.2 (81.2) 99.9 (100) 70.5 (82.7) 70.2 (81.2) 99.9 (100)
VP3 72.4 (84.5) 73.4 (86.1) 99.7 (99.2) 72.1 (84.0) 73.4 (86.6) 100 (100) 72.1 (84.0) 73.4 (86.6) 100 (100) 72.1 (84.0) 73.4 (86.6) 100 (100)
VP1 65.1 (74.9) 68.8 (78.5) 99.8 (99.3) 65.1 (74.9) 68.5 (78.5) 99.8 (99.3) 65.3 (75.6) 68.8 (78.5) 99.8 (99.3) 65.1 (74.9) 68.8 (78.5) 99.8 (99.3)
2A 80.8 (94.0) 78.7 (93.3) 99.8 (100) 80.8 (94.0) 78.7 (93.3) 99.8 (100) 80.8 (94.0) 78.7 (93.3) 99.8 (100) 80.8 (94.0) 78.7 (93.3) 99.8 (100)
2B 76.3 (91.8) 81.8 (94.8) 100 (100) 76.3 (91.8) 81.8 (94.8) 100 (100) 76.3 (91.8) 81.8 (94.8) 100 (100) 76.3 (91.8) 81.8 (93.3) 100 (100)
2C 82.1 (97.6) 87.5 (97.6) 97.5 (98.8) 82.8 (97.0) 85.1 (96.4) 99.9 (100) 82.7 (97.0) 85.2 (96.4) 99.8 (100) 82.7 (97.0) 85.1 (96.4) 99.9 (100)
3A 82.8 (98.9) 100 (100) 82.4 (97.7) 85.4 (98.9) 82.4 (97.7) 100 (100) 85.4 (98.9) 82.4 (97.7) 100 (100) 85.4 (98.9) 82.4 (97.7) 100 (100)
3B 83.3 (95.5) 100 (100) 86.4 (95.5) 86.4 (90.9) 84.8 (95.5) 98.5 (100) 86.4 (90.9) 84.4 (95.5) 98.5 (100) 86.4 (90.9) 84.8 (95.5) 98.5 (100)
3C 86.7 (98.4) 99.6 (100) 86.5 (97.3) 89.6 (98.9) 86.5 (97.3) 100 (100) 89.6 (99.5) 86.5 (97.8) 99.6 (99.5) 89.6 (99.5) 86.5 (97.3) 100 (100)
3D 87.1 (97.8) 99.9 (100) 85.8 (97.6) 86.0 (97.8) 92.0 (97.8) 93.5 (99.8) 85.3 (97.0) 85.6 (97.0) 99.6 (99.3) 85.4 (97.4) 92.0 (97.8) 93.5 (99.8)
3′UTR 91.5 95.7 93.0 95.8 100 97.2 91.5 95.7 93.0 91.5 100 97.2
Genome 78.5 (90.7) 84.0 (92.0) 95.1 (98.8) 78.8 (90.5) 80.5 (91.0) 98.7 (99.9) 78.6 (90.5) 79.3 (90.9) 99.7 (99.7) 78.6 (90.50 79.1 (91.0) 99.7 (99.7)
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present in the three isolates, suggesting that RF108,
RF134, and RF146 isolates were antigenically indistin-
guishable from Sabin 3.
Phylogenetic analysis
Phylogenetic trees were constructed based on the P1, P2,
P3 and 3D genomic regions, respectively, with 22 PV3 (in-
cluding RF134, RF151, RF146 and RF108) strains and one
Sabin 2 strain (Fig. 1). In the regions of P1 and P2, the four
isolates in the study clustered together with most PV3 iso-
lates (including Sabin 3), but in P2, one PV3/PV2 intertypic
3D-recombinant PV (31974/Belarus) [17] and three PV3/
PV2 intertypic VP1 capsid-recombinant PV3 strains (P3/
Jinan/1/09, CHN6053/HeN/CHN/2002 and CHN5275/JX/
CHN/2001) [12] clustered with Sabin 2. In the P1, one
intertypic PV2/PV3 penta-recombinant PV2 (CHN1025,
five successive rounds of recombination occurred in the
VP1 capsid coding region and in the 2C, 3C (twice) and 3D
coding regions [11] clustered with Sabin 2. In the P3 and
3D, RF108 clustered with Sabin 2 and 31974/Belarus, while
RF134, RF146, and RF151 were grouped into a cluster of
the indigenous Sabin 3 and most of the PV3 isolates. How-
ever, the nucleotide identity of RF134 was not significantly
high (93.5 %), and RF134 could belong to another subclade.
Besides, phylogenetic analysis of 3D genomic regions on all
HEV-C reference strains could also indicate recombination
with other HEV-C serotypes as two PV3/PV1 intertypic
2C-recombinant PVs (IRA10852 and RA10853) [2], one
PV3/PV1 intertypic 3D-recombinant PV(3239/Belarus)
[17], and four PV3/HEV-C intertypic 3D-recombinant PVs
(FIN84-2493, FIN84-60212, Cambodia-02 and SWI10947)
[2, 18] (Additional file 2: Figure S2). The aforementioned
results clearly show that the phylogenetic analysis of differ-
ent genomic regions could indicate recombination posi-
tions between enteroviruses.
Recombination analysis
The above recombination hypothesis was further exam-
ined by Simplot and bootscanning analyses in Fig. 2.
Two of the four VRPVs (strains RF108, RF134, RF146,
and RF151), RF108 and RF134 strains, were found to
have recombination in one crossover site: 5′-UTR to 5′-
terminal of the 2C coding region and 5′-UTR to 5′-ter-
minal of the 3D coding region of the genome were the
Sabin 3 sequence and the 3′ part was the Sabin 2 se-
quence (PV3/PV2), respectively. The crossover site was
located in the 2C and 3D coding region (nt 4941 and
6621), respectively. In other words, the RF108 and
RF134 isolated from different patients indicated diverse
mosaic recombinant genomic structures composed of
sequences derived from Sabin 3 and from Sabin 2
(Fig. 2). The findings described above suggested that
RF108 and RF134 strains from Yunnan, China were
PV3/PV2 recombinant strains.
Temperature sensitivity
All four isolates were compared to Sabin 3 with regards
to replication capacity at 36 °C and 40 °C. The difference
in titers between the two temperatures was reduced sig-
nificantly more than 2 logarithms for all isolates as with
Sabin 3 (Additional file 3: Table S1). This indicates that
the four isolates were temperature-sensitive.
Discussion
Through the effective large-scale use of OPV, WPV3 has
not been detected around the world since 2012 [19].
There were many reports of AFP cases caused by
VDPV3 [10–12, 20–22], but AFP caused by VRPV3 has
rarely been reported. To date, only one report has de-
scribed AFP caused by VRPV3, which was a recombin-
ant [2]. In this study, four Sabin 3-related PVs (RF108,
RF134, RF146, and RF151) were isolated from aseptic
encephalitis cases in Yunnan, China in 2010, which were
classified as VRPVs by divergence (<0.6 %) in VP1
complete sequences and genetically unrelated to each
other [22]. Therefore, this result showed that the four
isolates did not result from a circulating strain [2].
In addition, all four isolates demonstrated most char-
acteristics of Sabin 3, such as the same NAg sites (except
RF146), two attenuated nucleotide positions (T472 and
T2034) [15], and a temperature-sensitive phenotype. The
T2034 (at Phe-91of VP3) was also a major determinant
Table 2 Nucleotide and amino acid substitutions of attenuation positions in oral PV vaccine strains Sabin 3 and four PV3 isolates
Strain 5′UTR VP3 VP1
Nucleotide (472) Nucleotide (2034) Amino acid (91) Nucleotide (2493) Amino acid (6)
Sabin 3 T T Phe C Thr
RF108 T T Phe T ILe
RF134 T T Phe T ILe
RF146 T T Phe T ILe
RF151 T T Phe T ILe
WPV3 C C Ser T ILe
The nucleotide mutation position refers to the complete genome, whereas the corresponding amino acid change is numbered according to the primary amino
acid sequence of a given protein after cleavage of the polyprotein precursor
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Fig. 1 Phylogenetic trees based on the P1, P2, P3 and 3D genomic regions generated by the neighbor-joining algorithm implemented in MEGA
(version 6.06) using the Kimura two-parameter substitution model and 1,000 bootstrap pseudo-replicates. ▲strains isolated in this investigation;
● other PV3 strains
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Fig. 2 Similarity plot and bootscanning analyses of the complete genome of 4 PV3 isolates using a sliding window of 200 nt moving in 20-nt
steps. The names of the viruses used as the reference strains were indicated in the square and the names of viruses of the query sequence were
indicated in the middle
Liu et al. Virology Journal  (2016) 13:162 Page 5 of 8
of temperature-sensitivity [23]. Besides this residue, an-
other 11 amino acid substitutions were suggested to be re-
lated to temperature sensitivity [23], and mutations of those
amino acids are also found in the four isolates (data not
shown). So, the molecular basis also shows that the four
isolates possess the same temperature-sensitive phenotype
as Sabin 3. Furthermore, a Thr-6→ Ile substitution of VP1
(nucleotide 2493) which has been frequently found in
VDPV3 and WPV3 strains appeared in all four isolates.
Recombination of PV3 also occurs in genome regions
as with HEV-Cs, including different serotypes of PVs,
and the crossover sites of recombinants may be located
in the P1, P2 or P3 coding region [2, 8, 24–28]. The 3′-
end of the 2C to 3′-UTR genome region of RF108 and
5′-end of 3D to 3′-UTR genome region of RF134 had
most homology with Sabin 2, respectively. This indicated
the crossover site of the two PV3 recombinants may be
located in the P2 and P3 genome regions. The 3D phylo-
genetic tree showed that RF108 was most relevant to Sa-
bin 2, suggesting genetic rearrangement had occurred
between these two strains. Interestingly, although RF134
was not sufficiently relevant to Sabin 2, our similarity
plot and bootscanning analyses of the genomic se-
quences of the RF134 strain and Sabin 2 showed recom-
bination sites in the nonstructural coding regions
(Fig. 2), recombination events were observed between
the RF108 or RF134 strain with Sabin 2, with support
values of more than 90 %. Obviously, recombination of
the RF108 or RF134 isolates had occurred with Sabin 2.
It was clear that the 3D phylogenetic analyses hinted at
recombination between enteroviruses as reported previ-
ously [29]. In previous reports of HEV-C 3D phylogenetic
trees, recombination strains with other HEV-C strains could
be determined: Cambodia-02, SWI10947, FIN84-60212 and
FIN84-2493 [2, 18]. However, the 3D phylogenetic tree does
not cover recombination that has occurred in structural
coding regions such as VP1 (as in P3/Jinan/1/09, CHN5275/
JX/CHN/2001, and CHN6053/HeN/CHN/2002). So, the
phylogenetic trees based on the different coding regions
could not only ascertain recombinants, they could also find
crossover genomic regions.
According to VRPV3 that differs from the OPV3 strain
by >1 % of nucleotide positions are estimated to have
replicated in one or more individuals for at least one
year after administration of an OPV dose [22], the four
strains were isolated within six months after the admin-
istration of OPV. So, the four strains should have kept
the most original genetic characteristics of Sabin 3 [2].
Conclusion
In this study, we have identified four VRPV3 strains, in-
cluding two type 3/type 2 intertypic recombinants, asso-
ciated with aseptic encephalitis. It is possible that VRPVs
and VDPVs still exist for a long period until OPV is
completely replaced with inactivated poliovirus vaccine.
VRPVs or VDPVs are not only often associated with re-
combination with different Sabin serotypes but also
non-Sabin enteroviruses [2, 30]. The recombination of
Sabin vaccine strains with other serotype or HEV-C
would be a critical factor for the potential of emerging
viruses and related disease outbreaks. Thus, it is essen-
tial to persistent surveillance of EVs (including PV).
Methods
Stool specimens and virus isolation
The PV3 RF108, RF134, RF146 and RF151 strains were
isolated from four fecal specimens of a five-year-old
boy, four-year-old boy, five-year-and-nine-month-old
girl and four-year-old girl, respectively (Additional file 4:
Table S2), in 2010 during an enterovirus surveillance in
Yunnan, China.
All of the children with aseptic meningitis received at
least three doses of OPV after birth. They did not show
signs of immunodeficiency at the time of presentation.
RD, KMB17, and A549 cell lines were used to isolate vi-
ruses from the stool specimens according to standard pro-
cedures [31]. All positive isolates were stored at −80 °C.
Viral RNA extraction, RT-PCR, sequencing and typing
The viral RNAs were extracted from cell culture super-
natants with a QIAamp Viral RNA Mini Kit (QIAGEN,
Valencia, CA, USA) according to the manufacturer’s in-
structions. RT-PCR was carried out using a PrimeScript™
One Step RT-PCR Kit Ver.2 (TaKaRa, Dalian, China) ac-
cording to the manufacturer’s protocol. The primer pairs
222 and 224 were used to amplify the partial VP1 gene
[32]. The partial VP1 sequences were compared with
sequences from GenBank using BLAST (http://
www.ncbi.nlm.nih.gov/BLAST/). In addition, all isolates
were identified by a microneutralization test with polio-
virus type-specific rabbit polyclonal antisera (Chinese
Academy of Medical Sciences and Peking Union Medical
College Institute of Medical Biology, Kunming, China).
The design of primers to amplify the complete genomes
were based on the published sequence of Sabin 3 and
primers were designed for “primer-walking” strategy as
described previously [31] (Additional file 5: Table S3).
The PCR positive products were sequenced using an
ABI 3730XL automatic sequencer (Applied Biosystems,
Foster City, CA, USA) at BGI Sequencing Company
(Beijing, China). Nucleotide sequences used in this study
have been deposited in GenBank under accession num-
bers KT946714–KT946717.
Sequence analysis
Phylogenetic trees were conducted using Molecular
Evolutionary Genetic Analysis (MEGA) version 6.06 soft-
ware as described previously [32]. The plot of nucleotide
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similarities was created using Simplot software version
3.5.1, with a sliding window of 200 nucleotides moving
in steps of 50 nucleotides [32]. Pairwise alignments of
the sequences were performed using Geneious Basic
5.6.5 software [32].
Temperature sensitivity
The temperature sensitivity of the four PV3 isolates was
assayed on a monolayer of Hep2 (human laryngeal tumor
cells). Two 24-well plates were inoculated with 50 μl of
undiluted virus stocks (Sabin 3 and four isolates). After ab-
sorption at 36 °C or 40 °C for 1 h, the unabsorbed virus was
removed, maintenance medium was added to each well and
the plates were continually incubated at 36 °C or 40 °C.
After 8 h and 24 h of post-infection, the cultural
supernatants were harvested, respectively and the cell
culture infectious dose 50 % was calculated by the
end-point dilution method in 96-well plates at 36 °C.
The isolate showing more than two logarithms reduc-
tion of the titers at 36 °C or 40 °C was considered to
be temperature sensitive [9].
Additional files
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neutralizing antigenic (NAg) sites 1 (VP1: 88–106), 2 (VP2: 163–169; VP2:
268–270; VP1:220–225), 3a (VP3: 54–61; VP3: 70–74; VP1: 286–291), and 3b
(VP2: 71–73; VP3: 75–79) for Sabin 3. (DOC 408 kb)
Additional file 2: Figure S2. Phylogenetic trees based on 3D genomic
regions of HEV-C generated by the neighbor-joining algorithm implemented
in MEGA (version 6.06) using the Kimura two-parameter substitution model
and 1,000 bootstrap pseudo-replicates.▲strains isolated in this investigation;
● other PV3 strains. (DOC 682 kb)
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